Veal GJ - Search Results

1

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chénard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R. Halford S, et al. Among authors: veal gj. Clin Cancer Res. 2023 Apr 14;29(8):1429-1439. doi: 10.1158/1078-0432.CCR-22-2263. Clin Cancer Res. 2023. PMID: 36652553 Free PMC article. Clinical Trial.

2

Population pharmacokinetic investigation of actinomycin-D in children and young adults.

Mondick JT, Gibiansky L, Gastonguay MR, Skolnik JM, Cole M, Veal GJ, Boddy AV, Adamson PC, Barrett JS. Mondick JT, et al. Among authors: veal gj. J Clin Pharmacol. 2008 Jan;48(1):35-42. doi: 10.1177/0091270007310383. J Clin Pharmacol. 2008. PMID: 18094218

3

Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.

Veal GJ, Wild MJ, Barry MG, Back DJ. Veal GJ, et al. Br J Clin Pharmacol. 1994 Oct;38(4):323-8. doi: 10.1111/j.1365-2125.1994.tb04361.x. Br J Clin Pharmacol. 1994. PMID: 7833221 Free PMC article.

4

Retinoid X receptors and retinoid response in neuroblastoma cells.

Rana B, Veal GJ, Pearson AD, Redfern CP. Rana B, et al. Among authors: veal gj. J Cell Biochem. 2002;86(1):67-78. doi: 10.1002/jcb.10192. J Cell Biochem. 2002. PMID: 12112017

5

Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11.

Jounaidi Y, Chen CS, Veal GJ, Waxman DJ. Jounaidi Y, et al. Among authors: veal gj. Mol Cancer Ther. 2006 Mar;5(3):541-55. doi: 10.1158/1535-7163.MCT-05-0321. Mol Cancer Ther. 2006. PMID: 16546968

6

Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.

Kewn S, Hoggard PG, Henry-Mowatt JS, Veal GJ, Sales SD, Barry MG, Back DJ. Kewn S, et al. Among authors: veal gj. AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):793-802. doi: 10.1089/088922299310692. AIDS Res Hum Retroviruses. 1999. PMID: 10381167

7

Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors.

Veal GJ, Agrawal S, Byrn RA. Veal GJ, et al. Antiviral Res. 1998 Apr;38(1):63-73. doi: 10.1016/s0166-3542(98)00004-7. Antiviral Res. 1998. PMID: 9614005

8

Development and validation of LC-MS/MS with in-source collision-induced dissociation for the quantification of pegcantratinib in human skin tumors.

Zangarini M, Rajan N, Danilenko M, Berry P, Traversa S, Veal GJ. Zangarini M, et al. Among authors: veal gj. Bioanalysis. 2017 Feb;9(3):279-288. doi: 10.4155/bio-2016-0199. Epub 2017 Jan 23. Bioanalysis. 2017. PMID: 28111963 Free PMC article.

9

Metabolism of Zidovudine.

Veal GJ, Back DJ. Veal GJ, et al. Gen Pharmacol. 1995 Nov;26(7):1469-75. doi: 10.1016/0306-3623(95)00047-x. Gen Pharmacol. 1995. PMID: 8690233 Review.

10

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Osborne C, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O. Martinez-Soria N, et al. Among authors: veal gj. Cancer Cell. 2019 Apr 15;35(4):705. doi: 10.1016/j.ccell.2019.03.012. Cancer Cell. 2019. PMID: 30991028 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page